Cleared Traditional

K031000 - LABSYSTEM III EP LABORATORY W/WINDOWS P...

K031000 is the FDA 510(k) clearance for LABSYSTEM III EP LABORATORY W/WINDOWS P... by C.R. Bard, Inc.. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K031000 · C.R. Bard, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2003
Decision
64d
Days
Class 2
Risk

K031000 is an FDA 510(k) clearance for the LABSYSTEM III EP LABORATORY W/WINDOWS PLATFORM & WINDOWS EP SOFTWARE VERSION 1.0. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Lowell, US). The FDA issued a Cleared decision on June 3, 2003 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K031000 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2003
Decision Date June 03, 2003
Days to Decision 64 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 125d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K031000.
INFINITY MEGACARE
K031970 · Siemens Medical Solutions USA, Inc. · Sep 2003
PYRAMIS ECG MANAGEMENT SYSTEM MODEL NUMBERS, 92600 AND 92601
K032038 · Quinton, Inc. · Sep 2003
CARDIOSOFT/CASE CARDIAC TESTING SYSTEM
K031561 · Ge Medical Systems Information Technologies · Aug 2003
CARTO XP AND QWIKMAP EP NAVIGATION SYSTEM
K020863 · Biosense Webster, Inc. · Jan 2003
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
CARTO XP EP NAVIGATION SYSTEM
K013083 · Biosense Webster, Inc. · Nov 2001